Travere Therapeutics has transitioned into a rare disease commercial platform, driven by FILSPARI’s growth in IgAN and recent FSGS approval. More on TVTX stock.

Sionna Therapeutics targets cystic fibrosis with novel CFTR/NBD1 stabilization; key 2026 readouts and cash runway to 2028.

Discover how to replace traditional Excel chart objects with clean, customizable in-cell visualizations using a single ...

In today’s edition … How low can Congress go? … You give us your reactions to the Virginia vote … but first … When Keisha Lance Bottoms was Democratic mayor ...

The AI revolution is reaching everyone. As AI agents become more mainstream, we’ve seen the powerful impact they can have on all kinds of work and a wide variety of roles. At Microsoft, we’re leading ...

Microsoft Excel remains a cornerstone for data analysts, offering a wide array of functions to streamline workflows and enhance data accuracy. In this deep dive, Mo Chen highlights ten essential Excel ...

Ha Nguyen McNeill, senior official performing the duties of the administrator of the Transportation Security Administration, testifies during the DHS oversight hearing in the Cannon House office ...

For decades the data landscape was relatively static. Relational databases (hello, Oracle!) were the default and dominated, organizing information into familiar columns and rows. That stability eroded ...

Function Health, a startup that offers lab testing and body scans for early disease detection, scored nearly $300 million in series B funding, boosting its valuation to $2.5 billion. Redpoint Ventures ...

From electronic health records and blood tests to the stream of data from wearable devices, the amount of health information people generate is accelerating rapidly. Yet, many users struggle to ...